There are 2949 resources available
1795P - Anlotinib combined with etoposide as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): A single-arm, prospective phase II study
Presenter: Bo Shen
Session: E-Poster Display
Resources:
Abstract
1796P - Treatment patterns and survival for small cell lung cancer patients: A nationwide Danish register study
Presenter: Anders Green
Session: E-Poster Display
Resources:
Abstract
1797P - Efficacy and safety analysis of EP / EC regimen combined with first-line anlotinib hydrochloride in the treatment of extensive small cell lung cancer: Results from a phase II single-arm trial
Presenter: Tiandong Kong
Session: E-Poster Display
Resources:
Abstract
1798P - Carboplatin-paclitaxel (CP) chemotheraphy as salvage treatment for small cell lung cancer (SCLC): A real-world evidence analysis
Presenter: Alejandro Garcia-Alvarez
Session: E-Poster Display
Resources:
Abstract
1799P - Immune checkpoint inhibitor plus chemotherapy versus chemotherapy alone as first-line for extensive stage small cell lung cancer: A meta-analysis
Presenter: Thierry Landre
Session: E-Poster Display
Resources:
Abstract
1800P - Concordance between treatment-naive tissue and circulating tumour DNA (ctDNA) in late stage non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
Presenter: Corinna Woestmann
Session: E-Poster Display
Resources:
Abstract
1801P - Safety and efficacy of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer
Presenter: Chang Liu
Session: E-Poster Display
Resources:
Abstract
1802P - Serum identification of MYC-amplification in small cell lung cancer patients using droplet digital PCR
Presenter: Fionnuala Crowley
Session: E-Poster Display
Resources:
Abstract
1803P - Safety and efficacy of cisplatin (Cis) combined with sintilimab (Sin) and niraparib (Nir) in advanced solid tumours: A phase Ib study
Presenter: Yi Hu
Session: E-Poster Display
Resources:
Abstract
1804P - The efficacy of apatinib plus topotecan as laterline therapy for advanced small cell lung cancer
Presenter: Haifeng Qin
Session: E-Poster Display
Resources:
Abstract